A PAT roadmap should address data analysis, aggregation, visualization, and the smart utility of those data for greater process understanding.

The biologics drug substance manufacturing market is witnessing substantial expansion, largely due to the growing prevalence of chronic diseases, which is driving the need for biologics development ...

DelveInsight's Biologics Drug Substance Manufacturing Market Insights report provides the current and forecast market ...

Request To Download Free Sample of This Strategic Report @ Highlighted with 43 tables and 86 figures, this 160-page report ?Europe Biopharmaceuticals Market 2023-2033 by Product Type, Testing Service ...

Request To Download Free Sample of This Strategic Report @ Highlighted with 78 tables and 119 figures, this 215-page report ?Global Biopharmaceuticals Market 2023-2033 by Product Type, Testing ...

During a Senate HELP Committee hearing, RFK Jr. stated that President Trump is dedicated to bringing drug manufacturing "back ...

Catch up on January’s top pharma news, from major industry deals and cutting-edge medical innovations to advancements in ...

Find insight on Tencent, TikTok, Reach and more in the latest Market Talks covering Technology, Media and Telecom.

including WuXi AppTec and WuXi Biologics, as well as BGI Group, MGI and Complete Genomics. In late December, WuXi AppTec announced a deal to sell its U.S. and U.K. cell and gene unit, known as ...

Legislation would have cut Chinese businesses off from US WuXi executives say the companies continue to sign new clients WuXi AppTec Co. and WuXi Biologics Cayman Inc. said they see a brighter 2025 ...

WuXi AppTec Co. and WuXi Biologics Cayman Inc. said they see a brighter 2025 for the Chinese biotech and drug companies after the US Biosecure legislation that threatened to cut them out from ...